Mark Bodenrader - Net Worth and Insider Trading

Mark Bodenrader Net Worth

The estimated net worth of Mark Bodenrader is at least $796,871 dollars as of 2024-11-13. Mark Bodenrader is the See Remarks of Cerevel Therapeutics Holdings Inc and owns about 17,724 shares of Cerevel Therapeutics Holdings Inc (CERE) stock worth over $796,871. Details can be seen in Mark Bodenrader's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Bodenrader has not made any transactions after 2023-12-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Mark Bodenrader

To

Mark Bodenrader Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Bodenrader owns 1 companies in total, including Cerevel Therapeutics Holdings Inc (CERE) .

Click here to see the complete history of Mark Bodenrader’s form 4 insider trades.

Insider Ownership Summary of Mark Bodenrader

Ticker Comapny Transaction Date Type of Owner
CERE Cerevel Therapeutics Holdings Inc 2023-12-20 See Remarks

Mark Bodenrader Latest Holdings Summary

Mark Bodenrader currently owns a total of 1 stock. Mark Bodenrader owns 17,724 shares of Cerevel Therapeutics Holdings Inc (CERE) as of December 20, 2023, with a value of $796,871.

Latest Holdings of Mark Bodenrader

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CERE Cerevel Therapeutics Holdings Inc 2023-12-20 17,724 44.96 796,871

Holding Weightings of Mark Bodenrader


Mark Bodenrader Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark Bodenrader has made a total of 2 transactions in Cerevel Therapeutics Holdings Inc (CERE) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Cerevel Therapeutics Holdings Inc is the sale of 7,889 shares on December 20, 2023, which brought Mark Bodenrader around $326,762.

Insider Trading History of Mark Bodenrader

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark Bodenrader Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mark Bodenrader Ownership Network

Ownership Network List of Mark Bodenrader

No Data

Ownership Network Relation of Mark Bodenrader

Insider Network Chart

Mark Bodenrader Owned Company Details

What does Cerevel Therapeutics Holdings Inc do?

Who are the key executives at Cerevel Therapeutics Holdings Inc?

Mark Bodenrader is the See Remarks of Cerevel Therapeutics Holdings Inc. Other key executives at Cerevel Therapeutics Holdings Inc include director & See Remarks N Anthony Coles , Chief Scientific Officer John Renger , and Chief Medical Officer Ramiro Sanchez .

Cerevel Therapeutics Holdings Inc (CERE) Insider Trades Summary

Over the past 18 months, Mark Bodenrader made 2 insider transaction in Cerevel Therapeutics Holdings Inc (CERE) with a net sale of 9,784. Other recent insider transactions involving Cerevel Therapeutics Holdings Inc (CERE) include a net sale of 627,506 shares made by N Anthony Coles , a net sale of 37,652 shares made by Ramiro Sanchez , and a net sale of 24,572 shares made by Scott Akamine .

In summary, during the past 3 months, insiders sold 0 shares of Cerevel Therapeutics Holdings Inc (CERE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 966,157 shares of Cerevel Therapeutics Holdings Inc (CERE) were sold and 17,422,701 shares were bought by its insiders, resulting in a net purchase of 16,456,544 shares.

Cerevel Therapeutics Holdings Inc (CERE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cerevel Therapeutics Holdings Inc Insider Transactions

No Available Data

Mark Bodenrader Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Bodenrader. You might contact Mark Bodenrader via mailing address: C/o Cerevel Therapeutics Holdings Inc., 131 Dartmouth Street Suite 502, Boston Ma 02116.